Manufacturing

Pharma

Europe's generic drug makers are asking the bloc for a lifeline

Europe's energy crisis could halt certain generic drug manufacturing operations without EU intervention, a local lobbying group warns.
Fraiser Kansteiner Sep 28, 2022 10:49am

Novartis' spinoff-headed Sandoz sells Chinese plant for $15.1M

Sep 28, 2022 10:32am

Asymchem Labs in early planning for $697M manufacturing facility

Sep 27, 2022 9:51am

Emergent finalizes deal for Chimerix's smallpox drug Tembexa

Sep 27, 2022 9:15am

WuXi expansion tear continues with new oral production plant

Sep 27, 2022 8:45am

Ipsen upgrades Dublin manufacturing site

Sep 27, 2022 8:20am